Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -40.69% is 165% below its 4-year average of -15.37%, around the middle of its 4-year range (-76.86%–0.00%).
5.88% below its 12-month average of -38.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -8.28%.
RETURN ON ASSETS (ROA)
-40.69%
RETURN ON ASSETS (ROA) AVG TTM
-38.43%
RETURN ON ASSETS (ROA) AVG 3Y
-19.21%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.88%
CURRENT VS 3Y AVG
-111.76%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-26.21%
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$42.26M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
N/A
Market Cap
$41.95M
Return on Assets (ROA)
-57.95%
TTM Avg
4.78%
3Y Avg
-64.05%
5Y Avg
-66.64%
Market Cap
$41.83M
Return on Assets (ROA)
-5.70%
TTM Avg
-13.47%
3Y Avg
-29.01%
5Y Avg
-32.57%
Market Cap
$42.72M
Return on Assets (ROA)
-87.60%
TTM Avg
-55.36%
3Y Avg
-44.79%
5Y Avg
-43.77%
Market Cap
$42.83M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
Market Cap
$42.99M
Return on Assets (ROA)
-56.31%
TTM Avg
-47.91%
3Y Avg
-41.18%
5Y Avg
-35.79%
Market Cap
$44.02M
Return on Assets (ROA)
70.17%
TTM Avg
-36.93%
3Y Avg
-46.92%
5Y Avg
-57.84%
Market Cap
$44.71M
Return on Assets (ROA)
39.10%
TTM Avg
-36.27%
3Y Avg
-59.86%
5Y Avg
-86.70%
Market Cap
$44.72M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $42.26M | -40.69% | -38.43% | -19.21% | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -57.95% | 4.78% | -64.05% | -66.64% |
| Precipio, Inc. (PRPO)vs › | $41.83M | -5.70% | -13.47% | -29.01% | -32.57% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -87.60% | -55.36% | -44.79% | -43.77% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -128.10% | -35.87% | -35.25% | -29.40% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -56.31% | -47.91% | -41.18% | -35.79% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 70.17% | -36.93% | -46.92% | -57.84% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 39.10% | -36.27% | -59.86% | -86.70% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -143.30% | -71.59% | -49.53% | -40.25% |
| Veru Inc. (VERU)vs › | $39.64M | -36.75% | -69.37% | -96.71% | -69.92% |
ROA
-40.7%
ROE
-66.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -76.86% |
| 2024-12-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2021-12-31 | 0.00% |
